Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-31

Clinical Trial Update: Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the probiotic BIO-K+ for symptoms of irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIO-K

Snippet

Sponsor: Bio-K Plus International Inc. | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED